Point72 Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$114M Buy
1,334,500
+1,328,300
+21,424% +$118M 0.15% 146
2025
Q4
$490K Buy
6,200
+4,400
+244% +$345K ﹤0.01% 3238
2025
Q3
$144K Hold
1,800
﹤0.01% 2180
2025
Q2
$164K Sell
1,800
-500
-22% -$45.6K ﹤0.01% 2015
2025
Q1
$216K Sell
2,300
-12,500
-84% -$1.12M ﹤0.01% 1806
2024
Q4
$1.35M Buy
14,800
+2,300
+18% +$219K ﹤0.01% 1389
2024
Q3
$1.3M Buy
+12,500
New +$1.27M ﹤0.01% 1334
2023
Q1
Sell
-8,000
Closed -$630K 2269
2022
Q4
$630K Buy
+8,000
New +$600K ﹤0.01% 1121
2017
Q2
Sell
-399,300
Closed -$29.2M 848
2017
Q1
$29.2M Buy
+399,300
New +$28M 0.16% 169

Other funds holding CL

Point72 Asset Management's CL Position: Q1 2026 in Review

Point72 Asset Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 234,869 shares — an estimated $20.9M sold.

Point72 Asset Management first reported a position in CL in Q1 2016 and held it in 17 quarters. The position peaked at $113M in Q4 2022. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Point72 Asset Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 234,869 Colgate-Palmolive shares in Q1 2026, an estimated $20.9M.
  • Point72 Asset Management first reported a position in Colgate-Palmolive in Q1 2016 and held it in 17 quarters.
  • Point72 Asset Management's Colgate-Palmolive position peaked at $113M in Q4 2022.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.